A Note on Biological Inefficiency
Sleep has historically been treated as a human requirement. Markets are less sentimental.
From the desk of Jillian Berk
Interim CEO, Apex Pharmaceutical Corp
Sleep has historically been protected by language that makes it sound natural, private, and inevitable. This language has been useful. It has also obscured the central commercial fact.
Every unmanaged hour produces a measurable drag on capacity. The modern enterprise has learned to optimize attention, movement, food intake, emotional resilience, and biometric compliance. Sleep remains one of the last large inefficiencies still defended as identity.
This defense will not survive contact with incentive.
The first organizations to understand sleep as an economic boundary rather than a biological constant will not describe themselves as coercive. They will describe themselves as adaptive. They will speak about flexibility, optionality, resilience, and access. The language will be humane because humane language lowers resistance.
Apex is interested in the point at which a human limitation becomes a market category. Not because the category is new. Because the permission structure is becoming legible.
The future does not arrive as a mandate. It arrives as a benefit.
Jillian Berk
Interim CEO
Apex Pharmaceutical Corp